Rarebase is a public benefit biotech company that aims to revolutionize drug discovery with a focus on speed and scale. Founded in 2020 and based in the San Francisco Bay Area, the company is led by a team of patients, scientists, advocates, and engineers. Rarebase employs high-throughput technology and proven scientific methods to develop disease-modifying therapies for a multitude of diseases simultaneously. The company is known for its commitment to innovation in the field of biotechnology and its dedication to addressing the needs of medically underserved patient communities.

This partner doesn't have any research opportunities yet.
This partner doesn't have any news stories yet.